SC Filed 2021-02-08 Event — SEC 0001193125-21-032458 →

Bain Capital Life Sciences Fund, L.P. → Arcutis Biotherapeutics, Inc. ARQT

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (9.8 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

9 transactions

6 buys · 3 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

14 filings by this filer

13 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 9.78

20,485,453 shares short · -5.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $12.35M

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-03	Burnett Patrick	officer	Sale	955	$26.12	$25K
2026-08-03	Matsuda Masaru	officer	Sale	1,230	$26.12	$32K
2026-08-03	Watanabe Todd	director, officer	Sale	4,375	$26.12	$114K
2026-06-05	Heron Patrick J	director	Award	5,778	—	—
2026-06-05	Heron Patrick J	director	Award	16,667	$21.23	$354K
2026-06-05	LIN SUE-JEAN	director	Award	5,778	—	—
2026-06-05	LIN SUE-JEAN	director	Award	16,667	$21.23	$354K
2026-06-05	Welgus Howard G.	director	Award	5,778	—	—
2026-06-05	Welgus Howard G.	director	Award	16,667	$21.23	$354K

Other 13D/G Filings on Arcutis Biotherapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-07	SCHEDULE 13G	STATE STREET CORP	—	—	view →
2023-10-26	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2022-06-28	SC	ORBIMED ADVISORS LLC	—	—	view →
2021-05-12	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-02-09	SC	Frazier Life Sciences VIII, L.P.	—	—	view →
2021-02-09	SC	ORBIMED ADVISORS LLC	—	—	view →
2020-10-07	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by Bain Capital Life Sciences Fund, L.P.

Filed	Form	Issuer	Stake	Shares
2022-08-17	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-08-27	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-08-11	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-06-11	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2021-03-26	SC	Aptinyx Inc.	—	—	view →
2020-12-14	SC	Dicerna Pharmaceuticals Inc	—	—	view →
2020-10-27	SC	Aptinyx Inc.	—	—	view →
2020-05-28	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2020-03-12	SC	DYNAVAX TECHNOLOGIES CORP	—	—	view →
2020-01-16	SC	Aptinyx Inc.	—	—	view →
2019-12-06	SC	Dicerna Pharmaceuticals Inc	—	—	view →
2019-11-21	SC	Dicerna Pharmaceuticals Inc	—	—	view →
2019-05-31	SC	Dicerna Pharmaceuticals Inc	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →